None listed
Conditions
Brief summary
In this study, 43 people with diabetes referred to a community nursing organisation which visits patients in their home will be recruited in a prospective study. The current diabetes management of this group will be described. Participants’ individual needs will be assessed by a Diabetes Team, consisting of an endocrinologist linked to an in-home credentialled diabetes educator (CDE) through video-conferencing. The impact of individualised management on outcomes important to older people, that is, quality of life, wellbeing, treatment satisfaction, as well as biomedical markers will then determine the resources needed to undertake the assessments and management.
Interventions
This study will assess older clients newly registered to a community home nursing organisation that have been referred for diabetes management, and will identify each persons current management, including medications and community supports, and whether these are aligned with best practice (The McKellar Guidelines for Managing Older People with Diabetes in Residential and Other Care Settings; IDF Global Guideline for Managing Older People with Type 2 Diabetes; RACGP Guideline - General Practice M
This study will assess older clients newly registered to a community home nursing organisation that have been referred for diabetes management, and will identify each persons current management, including medications and community supports, and whether these are aligned with best practice (The McKellar Guidelines for Managing Older People with Diabetes in Residential and Other Care Settings; IDF Global Guideline for Managing Older People with Type 2 Diabetes; RACGP Guideline - General Practice Management of Type 2 Diabetes). We will ascertain the capacity of older participants for self-management and risk management, and a person-centred, individualised management plan will be developed by a Diabetes Team, consisting of a credentialled diabetes educator (CDE) and endocrinologist, working together with the older community member. The individualised management plan will take into account factors such as an individual’s glycaemic control, the functional status of the person, presence of comorbidities, and associated medical treatments. Participants will be reviewed by the endocrinologist via video-conferencing in the participant’s home with the participant and the CDE at baseline (week 2) and at 20 weeks after recruitment. It is anticipated the duration of each video-conference will be 30 minutes. Blood glucose management will be ascertained through the use of flash glucose monitoring, where data will be gathered for two weeks after recruitment into the study (week 0-2), and then two weeks after the 16-week intervention period (week 18-20). At 20 weeks the Diabetes Team will undertake the final review and we will review the impact of the intervention on measures important to community members, that is, quality of life, wellbeing, psychological distress and treatment satisfaction as well as biomedical markers, such as time spent outside optimum blood glucose target levels, hypoglycaemia episodes, HbA1c and safety, such as hospitalisations, recurrent infections and falls. Three months after the final review (approx. week 32), HbA1c will be collected.
Sponsors
Dr Rajna Ogrin
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
All newly registered clients to a community nursing organisation who: * are 65 years or older * have been diagnosed with type 2 diabetes * have been referred to the community nursing organisation for diabetes management * can speak and understand English
Exclusion criteria
* Are unable to consent, or don’t have a carer who is able to provide support for management of diabetes. * Are under the care of an Endocrinologist, and who have been seen by the endocrinologist in the last six months. * Do not currently have an acute infection, wound or recent change in condition that is affecting blood sugars * Have been referred to the community nursing organisation for assistance commencing an injectable diabetes medication. * Do not fit the inclusion criteria.
Outcome results
None listed